Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
DERM Quote, Financials, Valuation and Earnings
Last price:
$7.31
Seasonality move
:
0.65%
Day range:
$6.95 - $7.30
52-week range:
$3.54 - $8.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.70x
P/B ratio:
7.79x
Volume:
93.6K
Avg. volume:
167.7K
1-year change:
21.83%
Market cap:
$167.7M
Revenue:
$56.1M
EPS (TTM):
-$0.39
Earnings Data
Next earnings date for DERM
Aug 12
2025
Most recent earnings per share
-$0.18
Missed by $0.18
(May 14/2025)
Consensus Estimate
--
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DERM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $19.5M | -- | -- | -- | -- |
| 08/12/2025 | Q2 | $14.9M | -- | -- | -- | -- |
| 05/14/2025 | Q1 | $12.1M | $13.1M | -$0.18 | -- | -- |
| 03/26/2025 | Q4 | $14.2M | $13.6M | $0.08 | -- | -- |
| 11/12/2024 | Q3 | $14.4M | $14.6M | -$0.12 | -- | -- |
| 08/12/2024 | Q2 | $13.9M | $14.9M | -$0.17 | -- | -- |
| 05/13/2024 | Q1 | $14.1M | $13M | -$0.53 | -- | -- |
| 03/21/2024 | Q4 | $15M | $15.3M | -$0.12 | -- | -- |
| 11/07/2023 | Q3 | $16.9M | $34.5M | $0.80 | -- | -- |
| 06/30/2023 | Q2 | $14.8M | $17.2M | -$0.46 | -- | -- |
| 03/31/2023 | Q1 | -- | $12.2M | -$0.57 | -- | -- |
| 12/31/2022 | Q4 | -- | $16M | -$0.60 | -- | -- |
| 09/30/2022 | Q3 | -- | $16.1M | -$0.57 | -- | -- |
| 06/30/2022 | Q2 | -- | $18.3M | -$0.43 | -- | -- |
| 03/31/2022 | Q1 | -- | $23.3M | -$0.08 | -- | -- |
| 12/31/2021 | Q4 | -- | $17.5M | -$1.64 | -- | -- |
| 09/30/2021 | Q3 | -- | $19.6M | -$1.16 | -- | -- |
| 06/30/2021 | Q2 | -- | $15.3M | -$1.30 | -- | -- |
| 03/31/2021 | Q1 | -- | $10.7M | $0.03 | -- | -- |
| 12/31/2020 | Q4 | -- | $13.7M | $0.27 | -- | -- |
| 09/30/2020 | Q3 | -- | $9.4M | $0.00 | -- | -- |
| 06/30/2020 | Q2 | -- | $9.4M | $0.03 | -- | -- |
Journey Medical Earnings Questions
-
How Much did Journey Medical Generate in Revenue Last Quarter?
Journey Medical reported $13.1M worth of top line sales in its most recent quarter.
-
Did Journey Medical Beat Earnings Last Quarter?
Journey Medical announced earnings per share of -$0.18 which represents a miss of analyst forecast a -- per share.
-
Is Journey Medical Profitable?
Journey Medical reported $8.3M that represents $0.37 per share over the last quarter.
-
What is the Analyst Consensus for Journey Medical EPS Next Year?
Journey Medical's earnings are forecast to grow from -$0.72 per share to -- per share next year representing an increase of --.
-
When is Journey Medical's Earnings Date?
Journey Medical's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
